These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 38805126)

  • 1. The Role of the Human Microbiome in Epithelial Ovarian Cancer.
    Mahoney D
    Adv Exp Med Biol; 2024; 1452():97-105. PubMed ID: 38805126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study.
    Nené NR; Reisel D; Leimbach A; Franchi D; Jones A; Evans I; Knapp S; Ryan A; Ghazali S; Timms JF; Paprotka T; Bjørge L; Zikan M; Cibula D; Colombo N; Widschwendter M
    Lancet Oncol; 2019 Aug; 20(8):1171-1182. PubMed ID: 31300207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiome and Development of Ovarian Cancer.
    Dhingra A; Sharma D; Kumar A; Singh S; Kumar P
    Endocr Metab Immune Disord Drug Targets; 2022; 22(11):1073-1090. PubMed ID: 35532247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the Microbial Composition of Intratumoral, Reproductive Tract, and Gut Microbiota in Ovarian Cancer Patients.
    Zhou Q; Meng Q
    Adv Exp Med Biol; 2024; 1452():107-118. PubMed ID: 38805127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered cervicovaginal microbiota in premenopausal ovarian cancer patients.
    Morikawa A; Kawabata A; Shirahige K; Akiyama T; Okamoto A; Sutani T
    Gene; 2022 Feb; 811():146083. PubMed ID: 34856363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Oncobiome in Gastroenteric and Genitourinary Cancers.
    D'Antonio DL; Marchetti S; Pignatelli P; Piattelli A; Curia MC
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling the role of tissue colonized microbiome in ovarian cancer progression.
    Li M; He G; Kong F; Wang P; Han C; Ding Q; Jiang H; Deng S
    Comput Biol Med; 2024 Jul; 177():108641. PubMed ID: 38833797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The microbiome and gynaecological cancer development, prevention and therapy.
    Łaniewski P; Ilhan ZE; Herbst-Kralovetz MM
    Nat Rev Urol; 2020 Apr; 17(4):232-250. PubMed ID: 32071434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Microbiota in the Immunopathogenesis of Endometrial Cancer.
    Sobstyl M; Brecht P; Sobstyl A; Mertowska P; Grywalska E
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications.
    Yarbrough VL; Winkle S; Herbst-Kralovetz MM
    Hum Reprod Update; 2015; 21(3):353-77. PubMed ID: 25547201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota dysbiosis promotes the development of epithelial ovarian cancer
    Hu X; Xu X; Zeng X; Jin R; Wang S; Jiang H; Tang Y; Chen G; Wei J; Chen T; Chen Q
    Gut Microbes; 2023; 15(1):2221093. PubMed ID: 37282604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjusting for age improves identification of gut microbiome alterations in multiple diseases.
    Ghosh TS; Das M; Jeffery IB; O'Toole PW
    Elife; 2020 Mar; 9():. PubMed ID: 32159510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of peritoneal microbial features and tumor marker levels as potential diagnostic tools for ovarian cancer.
    Miao R; Badger TC; Groesch K; Diaz-Sylvester PL; Wilson T; Ghareeb A; Martin JA; Cregger M; Welge M; Bushell C; Auvil L; Zhu R; Brard L; Braundmeier-Fleming A
    PLoS One; 2020; 15(1):e0227707. PubMed ID: 31917801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling.
    Sipos A; Ujlaki G; Mikó E; Maka E; Szabó J; Uray K; Krasznai Z; Bai P
    Mol Med; 2021 Apr; 27(1):33. PubMed ID: 33794773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altering the Microbiome Inhibits Tumorigenesis in a Mouse Model of Oviductal High-Grade Serous Carcinoma.
    Chen L; Zhai Y; Wang Y; Fearon ER; Núñez G; Inohara N; Cho KR
    Cancer Res; 2021 Jun; 81(12):3309-3318. PubMed ID: 33863776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical review of the recent concept of artificial mechanical uterus design in relation to the maternal microbiome: An Update to past researches.
    Nami Y; Haghshenas B; Javanmard A; Samari M; Mohammadi N; Oroojalian F; Mokhtarzadeh A
    J Reprod Immunol; 2023 Mar; 156():103828. PubMed ID: 36796148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysbiosis of human microbiome and infectious diseases.
    Gupta A; Singh V; Mani I
    Prog Mol Biol Transl Sci; 2022; 192(1):33-51. PubMed ID: 36280324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilizing the Gastrointestinal Microbiota to Modulate Cattle Health through the Microbiome-Gut-Organ Axes.
    Welch CB; Ryman VE; Pringle TD; Lourenco JM
    Microorganisms; 2022 Jul; 10(7):. PubMed ID: 35889109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between vaginal microbiota and the progression of ovarian cancer.
    Li C; Feng Y; Yang C; Wang D; Zhang D; Luo X; Zhang H; Huang H; Zhang H; Jiang Y; Tan W; Liu J
    J Med Virol; 2023 Jul; 95(7):e28898. PubMed ID: 37409619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbial metabolism and colon cancer: can manipulations of the microbiota be useful in the management of gastrointestinal health?
    Belcheva A; Irrazabal T; Martin A
    Bioessays; 2015 Apr; 37(4):403-12. PubMed ID: 25601287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.